Drawing for GLYCONICS-DS

USPTO serial 79393828

GLYCONICS-DS

Reviewed by CopyMark Law Group

Reg. 7933279Status 700Registered
Filing date
Status date
Registration date
Sep 9, 2025
Examiner
GULIANO, ROBERT N
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GLYCONICS-DS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebecca Liebowitz

Rebecca Liebowitz Venable LLPP.O. Box 34385Comberton Road, ToftWashington, DC 20043-9998

Goods and services

ClassDescriptionStatusFirst use
009Scientific research and laboratory apparatus namely, spectrometers, portable spectrometers; optical measuring instruments, namely, optical readers; diagnostic testing equipment, other than for medical use, namely, diagnostic apparatus for testing and analysis of biological samples for laboratory and scientific purposes; laboratory apparatus and instruments for analysing biological samples for laboratory and scientific use; biological and microbiological testing equipment not for medical purposes, namely, spectrometers, portable spectrometers; optical apparatus, devices and instruments, namely, optical reflectors and optical lenses; scientific spectrometers; scientific apparatus, namely, spectroscopic apparatus in the nature of spectrometers for use in connection with Infrared spectroscopy, discrete filter spectroscopy, Attenuated Total Reflection (ATR) spectroscopy and line array plus Linear Variable filter spectroscopy; infrared spectrometers other than for medical use; analysers consisting of computers and downloadable computer programs for use in biological sample analysis for diagnostic purposes; microchips; semiconductors; data processing equipment in the nature of central and peripheral apparatus for accumulating, processing and storing data and computers; computer hardware, downloadable computer software and downloadable computer programs for analysing measurement data from spectrometers and spectroscopic apparatus; blank optical data carriers; parts and fittings for all the aforesaid goods, namely, a sample handling system specially adapted for use with spectrometers not for medical use comprised of a sample cartridge and a mechanism for docking the sample cartridge with the optical and spectroscopic portable system, to present the sample to the spectrometer for measurementACTIVE—
010Medical and veterinary apparatus and instruments, namely, spectrometers, hand held medical diagnostic devices, medical laboratory apparatus and instruments for analyzing biological samples for testing for biomarkers for blood borne diseases, chronic obstructive pulmonary disease, diabetes and cancer for medical and veterinary use; diagnostic, screening and analysis apparatus and instruments for use in the medical and veterinary fields, namely spectrometers and hand held medical diagnostic devices for testing for biomarkers for blood borne diseases, chronic obstructive pulmonary disease, diabetes and cancer; optical instruments and apparatus for medical purposes, namely, spectrometers and hand held medical diagnostic devices for testing for biomarkers for blood borne diseases, chronic obstructive pulmonary disease, diabetes and cancer; medical spectrometers, for use in connection with Infrared spectroscopy, discrete filter spectroscopy, Attenuated Total Reflection (ATR) spectroscopy and line array plus Linear Variable filter spectroscopy; infrared spectrometers for medical and veterinary use; biochemical and biological detection apparatus and instruments being diagnostic apparatus for obtaining, sampling, analysing and monitoring of biological material for medical and veterinary purposes for the detection of biomarkers for blood borne diseases, chronic obstructive pulmonary disease, diabetes and cancer; mobile apparatus and instruments for medical and veterinary testing purposes, namely, medical spectrometers and hand held medical diagnostic devices for the detection of biomarkers for blood borne diseases, chronic obstructive pulmonary disease, diabetes and cancer; medical and veterinary apparatus and instruments for diagnostic and testing purposes, namely, medical spectrometers in relation to metabolic diseases, infectious diseases, blood grouping, virology, antibodies, genetics, oncology, urology, hepatology, pharmacogenetics, cardiovascular medicine, autoimmune diseases and respiratory ailments; parts, fittings and accessories for the aforesaid goods, namely a sample handling system specially adapted for use with spectrometers for medical use comprised of a sample cartridge and a mechanism for docking the sample cartridge with the optical and spectroscopic portable system to present the sample to the spectrometer for measurementACTIVE—
042Medical and veterinary research services; medical research laboratory services; scientific laboratory services; information technology services, namely, planning, design and management of information technology systems; scientific and technological services, namely, research and design for detecting and analysing measurement data from spectrometers and spectroscopic apparatus; scientific services, namely, research, development, testing and analysis in the field of clinical diagnostics; scientific testing services in the field of testing, analysis and measurement of biological samples; scientific and technological services, namely, scientific research in the field of development of measuring and testing methods; product development in the nature of design and development of laboratory apparatus and instruments in the field of biomedical research, clinical research and medical research; services of a technical measurement and testing laboratory, namely, scientific research in the field of measurement and analysis of molecules and molecular characteristics in the field of life science and clinical applications; technical measuring services, namely, scientific research in the field of analysis and measurement of substances; technological analysis services in the field of biological and biochemical research and analysis; consultancy services in the field of medical devices and diagnostics for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 9, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 25, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 25, 2026FIMPFINAL DISPOSITION PROCESSED—
Dec 9, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 3, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 17, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 17, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 9, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 9, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 22, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 22, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 16, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 16, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 10, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Jun 10, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 10, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 10, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 8, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 8, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 8, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 8, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 30, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 30, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 30, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 7, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 7, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 7, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2024RFNTREFUSAL PROCESSED BY IB—
Jul 8, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 8, 2024RFRRREFUSAL PROCESSED BY MPU—
Jun 18, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 17, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 13, 2024DOCKASSIGNED TO EXAMINER—
Apr 23, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 19, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 18, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance